---
figid: PMC3844273__BMRI2013-524324.006
figlink: /pmc/articles/PMC3844273/figure/fig6/
number: Figure 6
caption: 'Hypothetical estrogen signaling pathways in human cerebral vascular endothelial
  cells. 17β-Estradiol (E2) passes through plasma and nuclear membranes activate nuclear
  ERβ through 3 mechanisms. First mechanism: 17β-estradiol causes ERβ dimerization,
  binds the ERβ dimer to the promoter of the estrogen-responsive gene, phosphorylation
  (P) of ERβ, and transcriptionally regulates the estrogen-responsive gene. The active
  genes produce mRNA molecules, which guide the synthesis of specific proteins. These
  proteins can then influence the behaviour of HCVECs. Second mechanism: activated
  ERβ modulates the function of transcription factors (TF) through protein-protein
  interactions. Third mechanism: 17β-estradiol (E2) binds to ERβ at the plasma membrane
  (mER). This estrogen-ERβ complex binds to adaptor 1 (Adaptor) protein and the signaling
  molecule such as c-Src, which mediates rapid signaling via PI3K-Akt and MAPK pathway
  to activate the promoter region of estrogen-responsive genes. Alternatively, 17β-estradiol
  (E2) passes through plasma, binds to GPER1 (GPER), and activates c-Src. c-Src activates
  matrix metalloproteinase (MMP). MMP cleaves pro-heparin-binding-epidermal growth
  factor (pro-HB-EGF) that transactivates epidermal growth factor receptor (EGFR).
  EGFR activates phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) and mitogen-activated
  protein kinase (MAPK) pathway. 17β-Estradiol (E2) GPER complex also activates cAMP
  production to restore EGF-activated MAPK to basal levels through protein kinase
  A (PKA) dependent inhibition of Raf-1 activity. Akt: protein kinase B; c-Src: protooncogene
  tyrosine-protein kinase Src; E2: 17β-estradiol; ER: estrogen receptor beta and/or
  G-protein-coupled estrogen receptor-1; EGFR: epidermal growth factor receptor; GPER:
  G-protein-coupled ER; MAPK: mitogen-activated protein kinase; mER: plasma membrane
  ER; MMP: matrix metalloproteinase; P: phosphorylation; PI3K: phosphatidylinositol
  3-kinase; PKA: protein kinase A; pro-HB-EGF: pro-heparin-binding-epidermal growth
  factor; Raf-1: RAF protooncogene serine/threonine-protein kinase; TF: transcription
  factors. JT modified the image by permission from Macmillan Publishers Ltd. Nature
  Reviews Endocrinology []. Copyright 2011 to Jian Tu for reuse of the original image
  from Nature Publishing Group (the original image is available in colour at http://www.nature.com/nrendo/index.html).'
pmcid: PMC3844273
papertitle: 'Estrogen Signaling through Estrogen Receptor Beta and G-Protein-Coupled
  Estrogen Receptor 1 in Human Cerebral Vascular Endothelial Cells: Implications for
  Cerebral Aneurysms.'
reftext: Jian Tu, et al. Biomed Res Int. 2013;2013:524324.
pmc_ranked_result_index: '118579'
pathway_score: 0.9712715
filename: BMRI2013-524324.006.jpg
figtitle: Hypothetical estrogen signaling pathways in human cerebral vascular endothelial
  cells
year: '2013'
organisms: Homo sapiens
ndex: ece96178-dec6-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3844273__BMRI2013-524324.006.html
  '@type': Dataset
  description: 'Hypothetical estrogen signaling pathways in human cerebral vascular
    endothelial cells. 17β-Estradiol (E2) passes through plasma and nuclear membranes
    activate nuclear ERβ through 3 mechanisms. First mechanism: 17β-estradiol causes
    ERβ dimerization, binds the ERβ dimer to the promoter of the estrogen-responsive
    gene, phosphorylation (P) of ERβ, and transcriptionally regulates the estrogen-responsive
    gene. The active genes produce mRNA molecules, which guide the synthesis of specific
    proteins. These proteins can then influence the behaviour of HCVECs. Second mechanism:
    activated ERβ modulates the function of transcription factors (TF) through protein-protein
    interactions. Third mechanism: 17β-estradiol (E2) binds to ERβ at the plasma membrane
    (mER). This estrogen-ERβ complex binds to adaptor 1 (Adaptor) protein and the
    signaling molecule such as c-Src, which mediates rapid signaling via PI3K-Akt
    and MAPK pathway to activate the promoter region of estrogen-responsive genes.
    Alternatively, 17β-estradiol (E2) passes through plasma, binds to GPER1 (GPER),
    and activates c-Src. c-Src activates matrix metalloproteinase (MMP). MMP cleaves
    pro-heparin-binding-epidermal growth factor (pro-HB-EGF) that transactivates epidermal
    growth factor receptor (EGFR). EGFR activates phosphatidylinositol 3-kinase-protein
    kinase B (PI3K-Akt) and mitogen-activated protein kinase (MAPK) pathway. 17β-Estradiol
    (E2) GPER complex also activates cAMP production to restore EGF-activated MAPK
    to basal levels through protein kinase A (PKA) dependent inhibition of Raf-1 activity.
    Akt: protein kinase B; c-Src: protooncogene tyrosine-protein kinase Src; E2: 17β-estradiol;
    ER: estrogen receptor beta and/or G-protein-coupled estrogen receptor-1; EGFR:
    epidermal growth factor receptor; GPER: G-protein-coupled ER; MAPK: mitogen-activated
    protein kinase; mER: plasma membrane ER; MMP: matrix metalloproteinase; P: phosphorylation;
    PI3K: phosphatidylinositol 3-kinase; PKA: protein kinase A; pro-HB-EGF: pro-heparin-binding-epidermal
    growth factor; Raf-1: RAF protooncogene serine/threonine-protein kinase; TF: transcription
    factors. JT modified the image by permission from Macmillan Publishers Ltd. Nature
    Reviews Endocrinology []. Copyright 2011 to Jian Tu for reuse of the original
    image from Nature Publishing Group (the original image is available in colour
    at http://www.nature.com/nrendo/index.html).'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK13
  - PRKACB
  - PRKACA
  - PRKAR1B
  - MAPK14
  - PRKAR1A
  - PIK3R5
  - PRKACG
  - MERTK
  - MAPK10
  - GPER1
  - HBEGF
  - MAPK3
  - MMP2
  - MMP3
  - MMP7
  - PRKAR2A
  - TF
  - MAPK9
  - AKT1
  - PIK3R4
  - PIK3CB
  - PIK3R3
  - PIK3CG
  - MMP27
  - MMP1
  - MMP25
  - MMP24
  - MMP21
  - MAPK1
  - PRKAR2B
  - MAPK11
  - PIK3CA
  - AKT2
  - PIK3R6
  - MAPK12
  - PIK3CD
  - EGFR
  - MMP10
  - MMP28
  - MMP23B
  - MMP15
  - MMP16
  - MAPK8
  - AKT3
  - MMP12
  - SRC
  - MMP13
  - MMP8
  - MMP17
  - MMP20
  - MMP9
  - MMP11
  - MMP14
  - MMP19
  - Cancer
genes:
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACB
  entrez: '5567'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACA
  entrez: '5566'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1B
  entrez: '5575'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR1A
  entrez: '5573'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKACG
  entrez: '5568'
- word: mER
  symbol: mer
  source: hgnc_alias_symbol
  hgnc_symbol: MERTK
  entrez: '10461'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: GPER
  symbol: GPER
  source: hgnc_prev_symbol
  hgnc_symbol: GPER1
  entrez: '2852'
- word: HB-EGF
  symbol: HBEGF
  source: hgnc_symbol
  hgnc_symbol: HBEGF
  entrez: '1839'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP2
  entrez: '4313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP3
  entrez: '4314'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP7
  entrez: '4316'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2A
  entrez: '5576'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP27
  entrez: '64066'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP25
  entrez: '64386'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP24
  entrez: '10893'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP21
  entrez: '118856'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PKA
  symbol: PKA
  source: bioentities_symbol
  hgnc_symbol: PRKAR2B
  entrez: '5577'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP10
  entrez: '4319'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP28
  entrez: '79148'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP23B
  entrez: '8510'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP15
  entrez: '4324'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP16
  entrez: '4325'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP12
  entrez: '4321'
- word: c-Src
  symbol: c-src
  source: hgnc_alias_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP13
  entrez: '4322'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP8
  entrez: '4317'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP17
  entrez: '4326'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP20
  entrez: '9313'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP11
  entrez: '4320'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP14
  entrez: '4323'
- word: MMP
  symbol: MMP
  source: bioentities_symbol
  hgnc_symbol: MMP19
  entrez: '4327'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
